| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.064 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |